SCHEMBL1800323

SCHEMBL1800323

CS(=O)(=O)c1cc(Cl)ccc1C=Cc1nc2cc(-c3ccccc3S(N)(=O)=O)ccc2[nH]1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 19/20 0.59
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
ALPL P05186 1/20 0.45
GLA P06280 1/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
ALPG P10696 1/20 0.45
PKM P14618 1/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1800320 1.00 TRPV1 (0.59) TRPV1KDM4EMEN1NPC1ALDH1A1
SCHEMBL1798183 0.89 TRPV1 (0.62) TRPV1KDM4EMEN1NPC1ALDH1A1
SCHEMBL1798187 0.89 TRPV1 (0.62) TRPV1KDM4EMEN1NPC1ALDH1A1
SCHEMBL1794872 0.89 TRPV1 (0.49) TRPV1KDM4EMEN1NPC1ALDH1A1
SCHEMBL1794876 0.89 TRPV1 (0.49) TRPV1KDM4EMEN1NPC1ALDH1A1
SCHEMBL1797022 0.88 TRPV1 (0.61) TRPV1KDM4EMEN1NPC1ALDH1A1
SCHEMBL1797026 0.88 TRPV1 (0.61) TRPV1KDM4EMEN1NPC1ALDH1A1
SCHEMBL1798125 0.85 TRPV1 (0.64) TRPV1KDM4EMEN1NPC1ALDH1A1
SCHEMBL2933393 0.85 TRPV1 (0.70) TRPV1KDM4EMEN1NPC1ALDH1A1
SCHEMBL1794736 0.85 TRPV1 (0.64) TRPV1KDM4EMEN1NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951829-B2 Benzimidazole modulators of VR1 JANSSEN PHARMACEUTICA NV (BE) 2011-05-31 US claimed
EP-2021330-B1 BENZIMIDAZOLE MODULATORS OF VR1 JANSSEN PHARMACEUTICA NV (BE) 2010-09-22 EP claimed
US-20070259936-A1 Benzimidazole Modulators of VR1 JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-08 US claimed
EP-2021330-B1 BENZIMIDAZOLE MODULATORS OF VR1 JANSSEN PHARMACEUTICA NV (BE) 2010-09-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259936-A1 Benzimidazole Modulators of VR1 VRK1, VRK2, VIL1 TRPV1 29/4885KDM4E 2796/4885MEN1 3925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.